Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002050709-25-000005·RELMADA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Relmada Therapeutics Inc
Common Stock ($.001 par value) · CUSIP: 75955J402
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Squadron Master Fund LP
Shares: 2,914,495.00 · Class: 8.8%
- Squadron Capital Management LLC
Shares: 3,298,500.00 · Class: 9.9%
- William Blank
Shares: 3,298,500.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050709-25-000005
- Form type
- SCHEDULE 13G/A
- Filer
- RELMADA THERAPEUTICS, INC.
- CIK
- CIK 1553643
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership